乳腺致密组织乳腺x线摄影对乳腺癌筛查的诊断价值

IF 0.8 Q4 REPRODUCTIVE BIOLOGY
Neda Shamsalizadeh, A. Khaki
{"title":"乳腺致密组织乳腺x线摄影对乳腺癌筛查的诊断价值","authors":"Neda Shamsalizadeh, A. Khaki","doi":"10.15296/ijwhr.2023.01","DOIUrl":null,"url":null,"abstract":"among women in the United States (1). Women at a younger age are more likely to have an aggressive case with a poorer prognosis. In the US, about 33,000 women younger than 45 years old are diagnosed with breast cancer annually. Among this age group, breast cancer is the leading cause for cancer-related deaths. It is predicted that around one in eight women will get breast cancer (2). Women younger than 45 years old account for approximately nine percent of all new cases of breast cancer in the US. In addition, dense breast tissue is more prevalent in younger women. Unlike fatty breast tissue, dense breast tissue absorbs more radiation during mammograms (3,4). Therefore, the accuracy and the diagnostic value of mammograms decrease for breast cancer detection among women with dense breast tissue (3). Dense breast tissue increases the risk for developing breast cancer by 4.7 times (1). Studies showed ultrasound (US) increases the breast cancer detection among women with dense breast tissue (1,5). In women with dense tissue adding US testing increased detection sensitivity as compared to only Mammogram screening (6). Regardless of breast type, density, and history, magnetic resonance imaging (MRI) has the highest, and mammography has the lowest sensitivity for breast cancer detection (7). The predicted total cost of metastatic breast cancer will be US$ 152.4 in 2030 (8). The cost-effectiveness of breast cancer screening with MRI among younger women with dense breast tissue is controversial. A false negative mammogram leads to a failure in finding breast cancer advancement early enough to prevent incurable stages and therefore a premature death (9). In addition, false positive mammograms can cause anxiety and additional costs for women with no breast cancer (9). A quality-assured mammographic screening program showed about two-thirds of women with breast cancer at the time of screening will remain underdiagnosed or the cancer will not be detected early enough so it progresses to metastatic cancer (9,10). Although only women with breast cancer can benefit from mammogram screenings, many of these women remain Diagnostic Value of Mammogram for Breast Cancer Screening in Women With Dense Breast Tissue","PeriodicalId":14346,"journal":{"name":"International Journal of Women's Health and Reproduction Sciences","volume":"6 1","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2023-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diagnostic Value of Mammogram for Breast Cancer Screening in Women With Dense Breast Tissue\",\"authors\":\"Neda Shamsalizadeh, A. Khaki\",\"doi\":\"10.15296/ijwhr.2023.01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"among women in the United States (1). Women at a younger age are more likely to have an aggressive case with a poorer prognosis. In the US, about 33,000 women younger than 45 years old are diagnosed with breast cancer annually. Among this age group, breast cancer is the leading cause for cancer-related deaths. It is predicted that around one in eight women will get breast cancer (2). Women younger than 45 years old account for approximately nine percent of all new cases of breast cancer in the US. In addition, dense breast tissue is more prevalent in younger women. Unlike fatty breast tissue, dense breast tissue absorbs more radiation during mammograms (3,4). Therefore, the accuracy and the diagnostic value of mammograms decrease for breast cancer detection among women with dense breast tissue (3). Dense breast tissue increases the risk for developing breast cancer by 4.7 times (1). Studies showed ultrasound (US) increases the breast cancer detection among women with dense breast tissue (1,5). In women with dense tissue adding US testing increased detection sensitivity as compared to only Mammogram screening (6). Regardless of breast type, density, and history, magnetic resonance imaging (MRI) has the highest, and mammography has the lowest sensitivity for breast cancer detection (7). The predicted total cost of metastatic breast cancer will be US$ 152.4 in 2030 (8). The cost-effectiveness of breast cancer screening with MRI among younger women with dense breast tissue is controversial. A false negative mammogram leads to a failure in finding breast cancer advancement early enough to prevent incurable stages and therefore a premature death (9). In addition, false positive mammograms can cause anxiety and additional costs for women with no breast cancer (9). A quality-assured mammographic screening program showed about two-thirds of women with breast cancer at the time of screening will remain underdiagnosed or the cancer will not be detected early enough so it progresses to metastatic cancer (9,10). Although only women with breast cancer can benefit from mammogram screenings, many of these women remain Diagnostic Value of Mammogram for Breast Cancer Screening in Women With Dense Breast Tissue\",\"PeriodicalId\":14346,\"journal\":{\"name\":\"International Journal of Women's Health and Reproduction Sciences\",\"volume\":\"6 1\",\"pages\":\"\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2023-01-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Women's Health and Reproduction Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15296/ijwhr.2023.01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"REPRODUCTIVE BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Women's Health and Reproduction Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15296/ijwhr.2023.01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"REPRODUCTIVE BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在美国女性中(1)。年轻女性更有可能出现侵袭性病例,预后较差。在美国,每年约有3.3万名45岁以下的女性被诊断出患有乳腺癌。在这一年龄组中,乳腺癌是癌症相关死亡的主要原因。据预测,大约八分之一的女性会患上乳腺癌(2)。在美国,45岁以下的女性约占所有新发乳腺癌病例的9%。此外,致密的乳腺组织在年轻女性中更为普遍。与脂肪乳腺组织不同,致密乳腺组织在乳房x光检查中吸收更多的辐射(3,4)。因此,乳腺组织致密的女性,乳房x光检查乳腺癌的准确性和诊断价值下降(3)。乳腺组织致密使乳腺癌发病风险增加4.7倍(1)。研究表明超声(US)提高了乳腺组织致密女性的乳腺癌检出率(1,5)。在致密组织的女性中,与仅进行乳房x光检查相比,添加US检查可提高检测灵敏度(6)。无论乳房类型、密度和病史如何,磁共振成像(MRI)的灵敏度最高。而乳房x光检查对乳腺癌的检测灵敏度最低(7)。预计到2030年,转移性乳腺癌的总成本将为152.4美元(8)。在乳腺组织致密的年轻女性中,MRI乳腺癌筛查的成本效益存在争议。假阴性乳房x光检查导致无法及早发现乳腺癌进展,从而阻止无法治愈的阶段,从而导致过早死亡(9)。假阳性的乳房x光检查会给没有乳腺癌的女性带来焦虑和额外的费用(9)。一个有质量保证的乳房x光检查项目显示,大约三分之二患有乳腺癌的女性在进行筛查时仍未得到充分诊断,或者没有及早发现癌症,从而发展为转移性癌症(9,10)。虽然只有患有乳腺癌的妇女才能从乳房x光检查中受益,但这些妇女中的许多人仍然认为乳房x光检查对乳腺致密组织妇女的乳腺癌筛查具有诊断价值
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Diagnostic Value of Mammogram for Breast Cancer Screening in Women With Dense Breast Tissue
among women in the United States (1). Women at a younger age are more likely to have an aggressive case with a poorer prognosis. In the US, about 33,000 women younger than 45 years old are diagnosed with breast cancer annually. Among this age group, breast cancer is the leading cause for cancer-related deaths. It is predicted that around one in eight women will get breast cancer (2). Women younger than 45 years old account for approximately nine percent of all new cases of breast cancer in the US. In addition, dense breast tissue is more prevalent in younger women. Unlike fatty breast tissue, dense breast tissue absorbs more radiation during mammograms (3,4). Therefore, the accuracy and the diagnostic value of mammograms decrease for breast cancer detection among women with dense breast tissue (3). Dense breast tissue increases the risk for developing breast cancer by 4.7 times (1). Studies showed ultrasound (US) increases the breast cancer detection among women with dense breast tissue (1,5). In women with dense tissue adding US testing increased detection sensitivity as compared to only Mammogram screening (6). Regardless of breast type, density, and history, magnetic resonance imaging (MRI) has the highest, and mammography has the lowest sensitivity for breast cancer detection (7). The predicted total cost of metastatic breast cancer will be US$ 152.4 in 2030 (8). The cost-effectiveness of breast cancer screening with MRI among younger women with dense breast tissue is controversial. A false negative mammogram leads to a failure in finding breast cancer advancement early enough to prevent incurable stages and therefore a premature death (9). In addition, false positive mammograms can cause anxiety and additional costs for women with no breast cancer (9). A quality-assured mammographic screening program showed about two-thirds of women with breast cancer at the time of screening will remain underdiagnosed or the cancer will not be detected early enough so it progresses to metastatic cancer (9,10). Although only women with breast cancer can benefit from mammogram screenings, many of these women remain Diagnostic Value of Mammogram for Breast Cancer Screening in Women With Dense Breast Tissue
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.60
自引率
14.30%
发文量
8
期刊介绍: All kind of knowledge contributing to the development of science by its content, value, level and originality will be covered by IJWHR. Problems of public health and their solutions are at the head of the windows opening us to the world. The "International Journal of Women''s Health and Reproduction Sciences” is a modern forum for scientific communication, covering all aspects women health and reproduction sciences, in basic and clinical sciences, mainly including: -Medical Education in Women Health and Reproduction Sciences -Cardiology in Women Health-Related Reproductive Problems -Sports Medicine in Women Health and Reproduction Sciences -Psychiatry in Women Health-Related Reproductive Problems -Antioxidant Therapy in Reproduction Medicine Sciences -Nutrition in Women Health and Reproduction Sciences -Defense Androgen and Estrogen -Fertility and Infertility -Urogynecology -Endometriosis -Endocrinology -Breast Cancer -Menopause -Puberty -Eroticism -Pregnancy -Preterm Birth -Vaginal Diseases -Sex-Based Biology -Surgical Procedures -Nursing in Pregnancy -Obstetrics/Gynecology -Polycystic Ovary Syndrome -Hyperandrogenism in Females -Menstrual Syndrome and Complications -Oncology of Female Reproductive Organs -Traditional Medicine in Women Reproductive Health -Ultrasound in Women Health Reproduction sciences -Stem Cell Research In Women Reproduction Sciences -Complementary Medicine in Women Reproductive Health -Female Sexual Dysfunction: Pathophysiology & Treatment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信